ROYAL BANK OF CANADA - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 149 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$1,000
-97.1%
12,678
-35.6%
0.00%
Q3 2018$34,000
+70.0%
19,693
+71.2%
0.00%
Q2 2018$20,000
-4.8%
11,5000.0%0.00%
Q1 2018$21,000
-89.9%
11,500
-87.6%
0.00%
Q4 2017$208,000
+160.0%
93,094
+237.4%
0.00%
Q3 2017$80,000
+95.1%
27,595
+198.8%
0.00%
Q2 2017$41,000
-62.7%
9,236
-60.5%
0.00%
Q1 2017$110,000
-19.7%
23,378
+4.2%
0.00%
Q4 2016$137,000
+132.2%
22,432
+107.7%
0.00%
Q3 2016$59,000
+13.5%
10,800
-20.7%
0.00%
Q2 2016$52,000
+20.9%
13,620
-11.0%
0.00%
Q1 2016$43,000
-53.3%
15,300
-5.9%
0.00%
Q4 2015$92,000
-51.6%
16,251
-54.5%
0.00%
Q3 2015$190,000
-73.1%
35,705
-58.1%
0.00%
Q2 2015$707,000
+82.2%
85,260
+1.2%
0.00%
Q1 2015$388,000
+580.7%
84,208
+355.2%
0.00%
Q4 2014$57,000
+9.6%
18,5000.0%0.00%
Q3 2014$52,000
-31.6%
18,5000.0%0.00%
Q2 2014$76,000
+18.8%
18,500
+54.2%
0.00%
Q1 2014$64,000
+1500.0%
12,000
+1251.4%
0.00%
Q3 2013$4,000
+300.0%
888
+241.5%
0.00%
Q2 2013$1,0002600.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q1 2018
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 477,621$1,065,0001.44%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,804$3,358,0001.18%
Nantahala Capital Management 7,000,000$15,610,0000.69%
Hikari Power Ltd 1,900,000$4,237,0000.50%
Trellus Management Company, LLC 112,500$251,0000.34%
Cheyne Capital Management (UK) LLP 206,500$462,0000.20%
KNOTT DAVID M 201,400$449,0000.18%
Paulson & Co. 4,000,000$8,920,0000.17%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,041,695$2,323,0000.15%
Clear Harbor Asset Management, LLC 318,460$710,0000.13%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders